Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

被引:1442
作者
Aggarwal, Parag [1 ]
Hall, Jennifer B. [1 ]
McLeland, Christopher B. [1 ]
Dobrovolskaia, Marina A. [1 ]
McNeil, Scott E. [1 ]
机构
[1] NCI Frederick, SAIC Frederick Inc, Nanotechnol Characterizat Lab, Adv Technol Program, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
Nanoparticles; Protein binding; Immunology; Biodistribution; Biocompatibility; SOLID-LIPID-NANOPARTICLES; HUMAN SERUM-ALBUMIN; POLY(D; L-LACTIC ACID) NANOPARTICLES; BLOOD-BRAIN-BARRIER; PERFUSED-RAT-LIVER; EQUILIBRIUM DIALYSIS; ADSORPTION PATTERNS; POLYMERIC NANOPARTICLES; COLLOIDAL CARRIERS; ENDOTHELIAL-CELLS;
D O I
10.1016/j.addr.2009.03.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Proteins bind the surfaces of nanoparticles, and biological materials in general, immediately upon introduction of the materials into a physiological environment. The further biological response of the body is influenced by the nanoparticle-protein complex. The nanoparticle's composition and surface chemistry dictate the extent and specificity of protein binding. Protein binding is one of the key elements that affects biodistribution of the nanoparticles throughout the body. Here we review recent research on nanoparticle physicochemical properties important for protein binding, techniques for isolation and identification of nanoparticle-bound proteins, and how these proteins can influence particle biodistribution and biocompatibility. Understanding the nanoparticle-protein complex is necessary for control and manipulation of protein binding. and allows for improved engineering of nanoparticles with favorable bioavailability and biodistribution. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:428 / 437
页数:10
相关论文
共 134 条
[1]  
Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO
[2]  
2-9
[3]  
ALYAUTDIN R, 1995, EUR J PHARM BIOPHARM, V41, P44
[4]   Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].
Alyautdin, RN ;
Tezikov, EB ;
Ramge, P ;
Kharkevich, DA ;
Begley, DJ ;
Kreuter, J .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74
[5]  
[Anonymous], IN ITS IMPL PLAN
[6]   Directed assembly of carbon nanotubes at liquid-liquid interfaces: Nanoscale conveyors for interfacial biocatalysis [J].
Asuri, P ;
Karajanagi, SS ;
Dordick, JS ;
Kane, RS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (04) :1046-1047
[7]   The protein-nanomaterial interface [J].
Asuri, Prashanth ;
Bale, Shyam Sundhar ;
Karajanagi, Sandeep S. ;
Kane, Ravi S. .
CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (06) :562-568
[8]   Increasing protein stability through control of the nanoscale environment [J].
Asuri, Prashanth ;
Karajanagi, Sandeep S. ;
Yang, Hoichang ;
Yim, Tae-Jin ;
Kane, Ravi S. ;
Dordick, Jonathan S. .
LANGMUIR, 2006, 22 (13) :5833-5836
[9]   Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding [J].
Banker, MJ ;
Clark, TH ;
Williams, JA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :967-974
[10]   140 Mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry [J].
Berggård, T ;
Arrigoni, G ;
Olsson, O ;
Fex, M ;
Linse, S ;
James, P .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (03) :669-687